The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 27, 2022

Filed:

Mar. 21, 2019
Applicant:

Northwestern University, Evanston, IL (US);

Inventors:

Ali Shilatifard, Chicago, IL (US);

Kaiwei Liang, Chicago, IL (US);

Edwin R. Smith, Chicago, IL (US);

Gary E. Schiltz, Naperville, IL (US);

Rama K. Mishra, Chicago, IL (US);

Kristen Stoltz, Chicago, IL (US);

Assignee:

Northwestern University, Evanston, IL (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07C 235/74 (2006.01); A61P 35/00 (2006.01); C07C 235/78 (2006.01); C07D 213/40 (2006.01); C07D 213/75 (2006.01); C07D 231/14 (2006.01); C07D 239/36 (2006.01); C07D 239/42 (2006.01); C07D 241/20 (2006.01); C07D 257/06 (2006.01); C07D 261/18 (2006.01); C07D 271/07 (2006.01); C07D 277/46 (2006.01);
U.S. Cl.
CPC ...
C07C 235/74 (2013.01); A61P 35/00 (2018.01); C07C 235/78 (2013.01); C07D 213/40 (2013.01); C07D 213/75 (2013.01); C07D 231/14 (2013.01); C07D 239/36 (2013.01); C07D 239/42 (2013.01); C07D 241/20 (2013.01); C07D 257/06 (2013.01); C07D 261/18 (2013.01); C07D 271/07 (2013.01); C07D 277/46 (2013.01); C07C 2601/08 (2017.05);
Abstract

Disclosed are compounds which may be utilized to inhibit transcription by RNA Polymerase II (Pol II), and in particular to disrupt the Super Elongation Complex (SEC). The compounds may be utilized in pharmaceutical compositions and methods for treating diseases and disorders associated with the biological activity of SEC, and in particular, diseases and disorders that are associated with high levels of expression of genes whose expression is SEC-dependent and that promote, support, or otherwise are required for the disease or disorder such as cancers.


Find Patent Forward Citations

Loading…